Rotavirus Vaccine NICU Study

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order for “ Collection of stool samples and data from infants in a US Neonatal Intensive Care Unit (NICU) that routinely administers Rotavirus Vaccine to a large number of infants while their presence in the unit” to Children’s Hospital of Philadelphia. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b)(1) “only one source is reasonably available”. This acquisition cannot be substituted because the Children’s Hospital Of Philadelphia (CHOP) is uniquely qualified to complete the project as its Neonatal Intensive Care Unit (NICU) is the only NICU in the USA that routinely administers Rotavirus Vaccine to the greatest number of infants annually which is approximately >180, while they are still in the NICU and stay there for a long period after the admission of the vaccine. Also, the Clinical Director of the Division of Infectious Disease and Associate Medical Director for Infection Prevention and Control at CHOP has the infectious disease and infection control scientific expertise and experience necessary to implement the project in the NICU. The NAICS code for this acquisition is 622110. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within seven (5) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be sent via email to Contract Specialist at [email protected] by COB May 4, 2020.